Caption Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-39,500
| Closed | -$1.88M | – | 1550 |
|
|
2025
Q3 | $1.88M | Buy |
39,500
+8,162
| +26% | +$395K | 0.11% | 868 |
|
|
2025
Q2 | $1.67M | Buy |
31,338
+26,738
| +581% | +$1.21M | 0.15% | 778 |
|
|
2025
Q1 | $186K | Buy |
+4,600
| New | +$195K | 0.01% | 1287 |
|
|
2024
Q4 | – | Sell |
-10,087
| Closed | -$289K | – | 1448 |
|
|
2024
Q3 | $289K | Buy |
+10,087
| New | +$263K | 0.03% | 1017 |
|
|
2024
Q2 | – | Sell |
-10,269
| Closed | -$259K | – | 1136 |
|
|
2024
Q1 | $259K | Buy |
10,269
+9,738
| +1,834% | +$234K | 0.03% | 971 |
|
|
2023
Q4 | $12.4K | Sell |
531
-734
| -58% | -$14.5K | ﹤0.01% | 1265 |
|
|
2023
Q3 | $64K | Sell |
1,265
-10,835
| -90% | -$504K | 0.01% | 1184 |
|
|
2023
Q2 | $565K | Sell |
12,100
-10,060
| -45% | -$461K | 0.1% | 794 |
|
|
2023
Q1 | $848K | Buy |
22,160
+17,060
| +335% | +$761K | 0.18% | 672 |
|
|
2022
Q4 | $279K | Buy |
+5,100
| New | +$219K | 0.05% | 1016 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1474 |
|
|
2020
Q2 | – | Sell |
-900
| Closed | -$19K | – | 919 |
|
|
2020
Q1 | $19K | Buy |
+900
| New | +$19.3K | 0.01% | 810 |
|
